Terms: = Cervical cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Clinical Outcome
39 results:
1. It is more than uterine fibroids: Incidental discovery of adenoma malignum of the cervix.
Abada E
Malays J Pathol; 2022 Dec; 44(3):533-538. PubMed ID: 36591722
[TBL] [Abstract] [Full Text] [Related]
2. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
3. A concise review on the role of BDNF-AS in human disorders.
Ghafouri-Fard S; Khoshbakht T; Taheri M; Ghanbari M
Biomed Pharmacother; 2021 Oct; 142():112051. PubMed ID: 34426254
[TBL] [Abstract] [Full Text] [Related]
4. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract] [Full Text] [Related]
5. HPV transcript expression affects cervical cancer response to chemoradiation.
Ruiz FJ; Inkman M; Rashmi R; Muhammad N; Gabriel N; Miller CA; McLellan MD; Goldstein M; Markovina S; Grigsby PW; Zhang J; Schwarz JK
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34255749
[TBL] [Abstract] [Full Text] [Related]
6. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract] [Full Text] [Related]
7. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
8. Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.
Gadducci A; Guerrieri ME; Cosio S
Crit Rev Oncol Hematol; 2019 Mar; 135():103-114. PubMed ID: 30819439
[TBL] [Abstract] [Full Text] [Related]
9. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India.
Bansal A; Das P; Kannan S; Mahantshetty U; Mulherkar R
Indian J Med Res; 2016 Sep; 144(3):359-365. PubMed ID: 28139534
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic value of p53 expression for patients with cervical cancer: a meta analysis.
Zhou R; Wei C; Liu J; Luo Y; Tang W
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():210-213. PubMed ID: 26595307
[TBL] [Abstract] [Full Text] [Related]
11. Immunophenotype and human papillomavirus status of serous adenocarcinoma of the uterine cervix.
Togami S; Sasajima Y; Kasamatsu T; Oda-Otomo R; Okada S; Ishikawa M; Ikeda S; Kato T; Tsuda H
Pathol Oncol Res; 2015 Apr; 21(2):487-94. PubMed ID: 25370301
[TBL] [Abstract] [Full Text] [Related]
12. BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy.
Henríquez-Hernández LA; Lloret M; Pinar B; Bordón E; Rey A; Lubrano A; Lara PC
Gynecol Oncol; 2011 Sep; 122(3):585-9. PubMed ID: 21708403
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.
Liao SY; Darcy KM; Randall LM; Tian C; Monk BJ; Burger RA; Fruehauf JP; Peters WA; Stock RJ; Stanbridge EJ
Gynecol Oncol; 2010 Mar; 116(3):452-8. PubMed ID: 19913895
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
[TBL] [Abstract] [Full Text] [Related]
15. BCL-2, p53 and HLA-DR antigen expression in surgically treated parotid cancer patients.
Genetzakis M; Gomatos IP; Georgiou AN; Giotakis J; Manolopoulos L; Papadimitriou K; Chra H; Leandros E; Tsigris C; Ferekidis EA
Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):417-24. PubMed ID: 18584190
[TBL] [Abstract] [Full Text] [Related]
16. Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence.
van der Veldt AA; Hooft L; van Diest PJ; Berkhof J; Buist MR; Comans EF; Hoekstra OS; Molthoff CF
Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1408-16. PubMed ID: 16841142
[TBL] [Abstract] [Full Text] [Related]
17. Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma.
Ikuta A; Saito J; Mizokami T; Nakamoto T; Yasuhara M; Nagata F; Nakajima M; Matsuo I; Yasuda K; Kanzaki H
Cancer Detect Prev; 2005; 29(6):528-36. PubMed ID: 16289387
[TBL] [Abstract] [Full Text] [Related]
18. TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells.
Vannucchi S; Chiantore MV; Fiorucci G; Percario ZA; Leone S; Affabris E; Romeo G
Oncogene; 2005 Apr; 24(15):2536-46. PubMed ID: 15735750
[TBL] [Abstract] [Full Text] [Related]
19. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract] [Full Text] [Related]
20. Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, HER-2/neu and DNA ploidy in early cervical carcinoma: correlation with clinical outcome.
Graflund M; Sorbe B; Sigurdardóttir S; Karlsson MG
Oncol Rep; 2004 Jul; 12(1):169-76. PubMed ID: 15201979
[TBL] [Abstract] [Full Text] [Related]
[Next]